awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37637905-E9832BED-5F38-4548-A2C1-8C77490E698E
Q37637905-E9832BED-5F38-4548-A2C1-8C77490E698E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37637905-E9832BED-5F38-4548-A2C1-8C77490E698E
Second-Line Treatment of NSCLC-The Pan-ErbB Inhibitor Afatinib in Times of Shifting Paradigms.
P2860
Q37637905-E9832BED-5F38-4548-A2C1-8C77490E698E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37637905-E9832BED-5F38-4548-A2C1-8C77490E698E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a42f17d44dc0b47e6cc4513a98bb7201252b8e12
P2860
EGFR L858M/L861Q cis Mutations Confer Selective Sensitivity to Afatinib.